Pericyazine is a rather [[sedation|sedating]] and [[anticholinergic]] [[antipsychotic]], and despite being classed with the typical antipsychotics, its risk of [[extrapyramidal symptoms|extrapyramidal side effects]] is comparatively low.<ref name = eTG>{{cite web|title=Approximate relative frequency (not intensity) of common adverse effects of antipsychotics (Table 8.21) [NB1]|date=February 2013|accessdate=2 November 2013|url=http://etg.tg.com.au/conc/desktop/index.htm?id=75114e7800512079b341de7fb82c953c|work=eTherapeutic Guidelines complete|publisher=Therapeutic Guidelines Limited}}</ref> It has a relatively high risk of causing [[hyperprolactinaemia]] and a moderate risk of causing [[weight gain]] and [[orthostatic hypotension]].<ref name = eTG/>

 

